AKT1 and non-small cell lung carcinoma: Further investigations into the molecular mechanism of action showed that celecoxib in combination with curcumol enhances the anti-proliferative and pro-apoptotic effects on NSCLC cells via actions on the anti-apoptotic AKT and ERK signaling pathways (Figure 9).